La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
DPH Aperçu des actions
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 4/6 |
| Performances passées | 0/6 |
| Santé financière | 1/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
Dechra Pharmaceuticals PLC Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | UK£38.66 |
| Plus haut sur 52 semaines | UK£41.46 |
| Plus bas sur 52 semaines | UK£24.73 |
| Bêta | 0.78 |
| 1Variation sur 1 mois | 0.68% |
| Variation sur 3 mois | 1.84% |
| Variation sur 1 an | 32.40% |
| 3Variation sur 3 ans | 5.57% |
| Variation sur 5 ans | 60.15% |
| Évolution depuis l'introduction en bourse | 2,828.79% |
Nouvelles et mises à jour récentes
Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Rendement pour les actionnaires
| DPH | GB Pharmaceuticals | GB Marché | |
|---|---|---|---|
| 7D | 0.2% | 0.2% | 0.3% |
| 1Y | 32.4% | 20.4% | 11.6% |
Rendement vs Industrie: DPH a dépassé le secteur UK Pharmaceuticals qui a rapporté 20.9 % au cours de l'année écoulée.
Rendement vs marché: DPH a dépassé le marché UK qui a rapporté 13.1 % au cours de l'année écoulée.
Volatilité des prix
| DPH volatility | |
|---|---|
| DPH Average Weekly Movement | 0.5% |
| Pharmaceuticals Industry Average Movement | 6.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 9.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Cours de l'action stable: DPH n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de DPH a diminué de 6% à 0% au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1997 | 2,457 | Ian Page | www.dechra.com |
Dechra Pharmaceuticals PLC Résumé des fondamentaux
| DPH statistiques fondamentales | |
|---|---|
| Capitalisation boursière | UK£4.40b |
| Bénéfices(TTM) | -UK£27.90m |
| Recettes(TTM) | UK£761.50m |
5.8x
Ratio P/S-157.8x
Ratio P/ELe site DPH est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| DPH compte de résultat (TTM) | |
|---|---|
| Recettes | UK£761.50m |
| Coût des recettes | UK£331.90m |
| Marge brute | UK£429.60m |
| Autres dépenses | UK£457.50m |
| Les revenus | -UK£27.90m |
Derniers bénéfices déclarés
Jun 30, 2023
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.24 |
| Marge brute | 56.42% |
| Marge bénéficiaire nette | -3.66% |
| Ratio dettes/capitaux propres | 64.6% |
Quelles ont été les performances à long terme de DPH?
Voir les performances historiques et les comparaisons